American Factory Tracker
About
PharmaceuticalsHolly Springs, North CarolinaAnnounced Dec 5, 2024

Amgen (Holly Springs Expansion)

See all projects by Amgen →

$1B expansion of the Holly Springs, North Carolina drug-substance manufacturing site announced December 5, 2024. Adds 370 additional full-time jobs on top of the original $550M / 355 jobs; brings total planned site investment above $1.5B and total site employment above 700 by 2032. Separately tracked from the 2021 initial facility.

Investment
$1.00B
Permanent jobs announced
370
Status
Under Construction
Expected opening
Jan 1, 2027
Why it matters

The pharmaceuticals context.

Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.

Project record

At a glance

Company
Amgen (Holly Springs Expansion)
Industry
Pharmaceuticals
Location
Holly Springs, North Carolina
Investment
$1.00B
Permanent jobs announced
370
Status
Under Construction
Announced
Dec 5, 2024
Expected opening
Jan 1, 2027
Added to tracker
Feb 25, 2026
Sources

Official references

  • Primary source
    https://www.amgen.com/newsroom/press-releases/2024/12/amgen-announces-$1-billion-manufacturing-expansion-in-north-carolina
Related

Other projects to know

In North Carolina
Across Pharmaceuticals
Back to the tracker/projects/amgen-holly-springs-expansion-holly-springs